Search

Your search keyword '"Mulleman D"' showing total 321 results

Search Constraints

Start Over You searched for: Author "Mulleman D" Remove constraint Author: "Mulleman D"
321 results on '"Mulleman D"'

Search Results

1. Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases

4. Recommandations françaises pour le diagnostic et la prise en charge des bursites septiques pré-patellaires et olécraniennes

5. Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.

6. POS1023 CHARACTERIZATION OF TRYPTOPHAN METABOLISM ALTERATION IN RHEUMATOID ARTHRITIS AND EVIDENCE FOR A THERAPEUTIC POTENTIAL OF AADAT ADMINISTRATION IN MICE

8. POS0630 ANTIDRUG ANTIBODIES ARE NEGATIVELY ASSOCIATED WITH RESPONSE TO BIOLOGICAL DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF THE ABIRISK STUDY

9. Réponse humorale après infection à SARS-CoV-2 des patients atteints de rhumatisme inflammatoire chronique en comparaison à celle de sujets sains : analyse des données des cohortes COVID-RIC2 et COVID-BIOTOUL

11. L’arthrite septique inter-apophysaire : ses caractéristiques cliniques et microbiologiques. Une étude rétrospective multicentrique dans le Grand-Ouest

12. POS0638 RECOMMENDATIONS FOR COST-EFFECTIVE USE OF BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN INFLAMMATORY ARTHRITIS: RESULTS FROM AN INTERNATIONAL DELPHI STUDY

15. Séroprévalence du SARS-CoV-2 chez 3845 patients atteints de rhumatisme inflammatoire chronique : résultats de la cohorte française COVID-RIC 1

18. SPONDIMMO is back : évolution radiographique et fonctionnelle des spondylodiscites infectieuses, cohorte prospective de 250 patients

20. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

25. MANAGEMENT AND OUTCOME OF SEPTIC ARTHRITIS OF NATIVE JOINT: A NATIONWIDE SURVEY

35. Quelle place pour l’immobilisation rachidienne dans la spondylodiscite infectieuse ? SPONDIMMO – cohorte prospective de 250 patients

37. FRI0449 MANAGEMENT AND OUTCOME OF SEPTIC ARTHRITIS OF NATIVE JOINT: A NATIONWIDE SURVEY

38. AB0310 TROUGH CONCENTRATION AND ESTIMATED CLEARANCE CAN DETECT IMMUNOGENICITY TO ADALIMUMAB IN RA PATIENTS: A PROSPECTIVE LONGITUDINAL MULTICENTRE STUDY

40. Myositis in patients with primary Sjögren’s syndrome: data from a French nationwide survey

41. Relationship between rituximab concentration and autoantibody levels in anti-neutrophil cytoplasmic antibody associated vasculitis

42. Influence of immunogenicity on long-term maintenance of adalimumab in spondyloarthritis

45. Poor assessment of BMD after a forearm fracture in women aged 50 years or older data from a French heath insurance database (SNIIRAM)

Catalog

Books, media, physical & digital resources